Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Alpha>1< anti-trypsin isotypes |
Is a |
True |
Human alpha1 proteinase inhibitor (substance) |
Inferred relationship |
Some |
|
Alpha>1< antitrypsin antigen (substance) |
Direct substance |
False |
Human alpha1 proteinase inhibitor (substance) |
Inferred relationship |
Some |
|
Alpha-1-antitrypsin measurement |
Has measured component (attribute) |
False |
Human alpha1 proteinase inhibitor (substance) |
Inferred relationship |
Some |
|
Alpha-1-antitrypsin clearance, feces and serum |
Has measured component (attribute) |
False |
Human alpha1 proteinase inhibitor (substance) |
Inferred relationship |
Some |
|
Alpha-1-antitrypsin phenotyping |
Has measured component (attribute) |
False |
Human alpha1 proteinase inhibitor (substance) |
Inferred relationship |
Some |
|
Serum A1 antitrypsin measurement |
Has measured component (attribute) |
False |
Human alpha1 proteinase inhibitor (substance) |
Inferred relationship |
Some |
|
Fecal A1 antitrypsin measurement |
Has measured component (attribute) |
False |
Human alpha1 proteinase inhibitor (substance) |
Inferred relationship |
Some |
|
Alpha-1-antitrypsin measurement |
Component |
True |
Human alpha1 proteinase inhibitor (substance) |
Inferred relationship |
Some |
1 |
Alpha-1-antitrypsin clearance, feces and serum |
Component |
True |
Human alpha1 proteinase inhibitor (substance) |
Inferred relationship |
Some |
1 |
Alpha-1-antitrypsin phenotyping |
Component |
True |
Human alpha1 proteinase inhibitor (substance) |
Inferred relationship |
Some |
1 |
Serum A1 antitrypsin measurement |
Component |
False |
Human alpha1 proteinase inhibitor (substance) |
Inferred relationship |
Some |
2 |
Fecal A1 antitrypsin measurement |
Component |
False |
Human alpha1 proteinase inhibitor (substance) |
Inferred relationship |
Some |
2 |
Alpha-1 antitrypsine humaine |
Is a |
False |
Human alpha1 proteinase inhibitor (substance) |
Inferred relationship |
Some |
|
Human alpha1 proteinase inhibitor 500 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Human alpha1 proteinase inhibitor (substance) |
Inferred relationship |
Some |
1 |
Human alpha1 proteinase inhibitor 500 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Human alpha1 proteinase inhibitor (substance) |
Inferred relationship |
Some |
1 |
Human alpha1 proteinase inhibitor 1 g powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Human alpha1 proteinase inhibitor (substance) |
Inferred relationship |
Some |
1 |
Human alpha1 proteinase inhibitor 1 g powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Human alpha1 proteinase inhibitor (substance) |
Inferred relationship |
Some |
1 |
Human alpha1 proteinase inhibitor only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Human alpha1 proteinase inhibitor (substance) |
Inferred relationship |
Some |
1 |
Human alpha1 proteinase inhibitor-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Human alpha1 proteinase inhibitor (substance) |
Inferred relationship |
Some |
1 |
Human alpha1 proteinase inhibitor-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Human alpha1 proteinase inhibitor (substance) |
Inferred relationship |
Some |
1 |
Product containing only human alpha1 proteinase inhibitor in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Human alpha1 proteinase inhibitor (substance) |
Inferred relationship |
Some |
1 |
Fecal A1 antitrypsin measurement |
Component |
True |
Human alpha1 proteinase inhibitor (substance) |
Inferred relationship |
Some |
1 |
Serum A1 antitrypsin measurement |
Component |
True |
Human alpha1 proteinase inhibitor (substance) |
Inferred relationship |
Some |
1 |